ESG News For Iqvia Holdings Inc

Under its COiMMUNITY Initiative, GSK is committing up to $2 million in 2024 to support adult immunization and health equityGSK launches new patient-centered resources to facilitate provider-patient vaccination conversations and recommendationsNew Q3 2023 Vaccine Track data show potential return of adult immunization rates to pre-pandemic levels, largely driven by an increase in Medicare and Medicaid claims

IQVIA™ (NYSE:IQV), has published its 2023 Environmental, Social and Governance (ESG) Report. The annual report provides a detailed account of the organization’s focus on reducing its environmental impact and commitment to accelerating positive outcomes for public health and patients.“At IQVIA our mission is to accelerate innovation for a healthier world. Our 87,000 healthcare focused employees integrate AI-powered analytics and healthcare expertise to solve the most complex problems for our life

For seven consecutive years Principal strategies earned a 4-star GRESB rating

IQVIA (NYSE:IQV) today published its 2021 Environmental, Social, and Governance (ESG) Report. The annual report highlights the significant efforts the company has made in advancing healthcare globally, increasing the diversity and engagement of its workforce, and reducing its global environmental footprint.“We are proud of the many business accomplishments we had this past year, but it is especially meaningful to see how our approximately 79,000 employees have embraced our ambitious Environmenta

Skin Releaf is on a mission to tackle skin issues for people of color

Scholarships to Increase Access and Completion for Minority, LGBTQ+, First Gen, and Low-income StudentsApplication Window Opens on Jan. 25